243 related articles for article (PubMed ID: 27653478)
21. Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca
Fernández-de Gortari E; Espinoza-Fonseca LM
J Biol Chem; 2018 Aug; 293(32):12405-12414. PubMed ID: 29934304
[TBL] [Abstract][Full Text] [Related]
22. Role of conformational sampling of Ser16 and Thr17-phosphorylated phospholamban in interactions with SERCA.
Sayadi M; Feig M
Biochim Biophys Acta; 2013 Feb; 1828(2):577-85. PubMed ID: 22959711
[TBL] [Abstract][Full Text] [Related]
23. Protein docking and steered molecular dynamics suggest alternative phospholamban-binding sites on the SERCA calcium transporter.
Alford RF; Smolin N; Young HS; Gray JJ; Robia SL
J Biol Chem; 2020 Aug; 295(32):11262-11274. PubMed ID: 32554805
[TBL] [Abstract][Full Text] [Related]
24. Atomic-level mechanisms for phospholamban regulation of the calcium pump.
Espinoza-Fonseca LM; Autry JM; Ramírez-Salinas GL; Thomas DD
Biophys J; 2015 Apr; 108(7):1697-1708. PubMed ID: 25863061
[TBL] [Abstract][Full Text] [Related]
25. Role of nucleotides in stabilization of the phospholamban/cardiac Ca²⁺ pump inhibitory complex examined with use of metal fluorides.
Chen Z
FEBS J; 2015 Nov; 282(22):4402-14. PubMed ID: 26337774
[TBL] [Abstract][Full Text] [Related]
26. Novel approach for quantification of endoplasmic reticulum Ca
Bovo E; Nikolaienko R; Bhayani S; Kahn D; Cao Q; Martin JL; Kuo IY; Robia SL; Zima AV
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1323-H1331. PubMed ID: 30901276
[TBL] [Abstract][Full Text] [Related]
27. Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers.
Singh DR; Dalton MP; Cho EE; Pribadi MP; Zak TJ; Šeflová J; Makarewich CA; Olson EN; Robia SL
J Mol Biol; 2019 Nov; 431(22):4429-4443. PubMed ID: 31449798
[TBL] [Abstract][Full Text] [Related]
28. Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase.
Kirby TL; Karim CB; Thomas DD
Biochemistry; 2004 May; 43(19):5842-52. PubMed ID: 15134458
[TBL] [Abstract][Full Text] [Related]
29. Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.
Hou Z; Kelly EM; Robia SL
J Biol Chem; 2008 Oct; 283(43):28996-9003. PubMed ID: 18708665
[TBL] [Abstract][Full Text] [Related]
30. Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer.
Mueller B; Karim CB; Negrashov IV; Kutchai H; Thomas DD
Biochemistry; 2004 Jul; 43(27):8754-65. PubMed ID: 15236584
[TBL] [Abstract][Full Text] [Related]
31. Effect of Phosphorylation on Interactions between Transmembrane Domains of SERCA and Phospholamban.
Martin PD; James ZM; Thomas DD
Biophys J; 2018 Jun; 114(11):2573-2583. PubMed ID: 29874608
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase.
Pallikkuth S; Blackwell DJ; Hu Z; Hou Z; Zieman DT; Svensson B; Thomas DD; Robia SL
Biophys J; 2013 Oct; 105(8):1812-21. PubMed ID: 24138857
[TBL] [Abstract][Full Text] [Related]
33. Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state.
Espinoza-Fonseca LM; Autry JM; Thomas DD
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):37-41. PubMed ID: 25983321
[TBL] [Abstract][Full Text] [Related]
34. Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2010 Jan; 285(5):3253-60. PubMed ID: 19948724
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional dynamics of an integral membrane protein complex modulated by lipid headgroup charge.
Li J; James ZM; Dong X; Karim CB; Thomas DD
J Mol Biol; 2012 May; 418(5):379-89. PubMed ID: 22381409
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
37. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.
Afara MR; Trieber CA; Ceholski DK; Young HS
Biochemistry; 2008 Sep; 47(36):9522-30. PubMed ID: 18702513
[TBL] [Abstract][Full Text] [Related]
38. Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents.
Chen Z; Stokes DL; Rice WJ; Jones LR
J Biol Chem; 2003 Nov; 278(48):48348-56. PubMed ID: 12972413
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump.
Cleary SR; Fang X; Cho EE; Pribadi MP; Seflova J; Beach JR; Kekenes-Huskey PM; Robia SL
J Biol Chem; 2022 Jul; 298(7):102060. PubMed ID: 35605666
[TBL] [Abstract][Full Text] [Related]
40. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban.
Gustavsson M; Verardi R; Mullen DG; Mote KR; Traaseth NJ; Gopinath T; Veglia G
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17338-43. PubMed ID: 24101520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
